Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | DNMT3A |
Variant | E240* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | DNMT3A E240* results in a premature truncation of the Dnmt3a protein at amino acid 240 of 912 (UniProt.org). E240* has not been characterized, however, due to the effects of other truncation mutations downstream of E240 (PMID: 28872462, PMID: 26595813, PMID: 35639959), is predicted to lead to a loss of Dnmt3a protein function. |
Associated Drug Resistance | |
Category Variants Paths |
DNMT3A mutant DNMT3A inact mut DNMT3A E240* |
Transcript | NM_022552.5 |
gDNA | chr2:g.25248174C>A |
cDNA | c.718G>T |
Protein | p.E240* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011532667.4 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_017003526.1 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_047443598.1 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_011532667.3 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_022552.4 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_011532664.3 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_047443594.1 | chr2:g.25246701C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_175629.2 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_001320893.1 | chr2:g.25246725C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_017003527.1 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_005264177 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_011532664.2 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_175629.2 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_047443596.1 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_017003526.2 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_017003527.2 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_001320893 | chr2:g.25246725C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_005264175 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_011532667 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_047443599.1 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_175629 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_022552.5 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_047443597.1 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_047443593.1 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_011532664 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_001320893.1 | chr2:g.25246725C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_022552 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_005264177.4 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_005264175.5 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_017003526 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
NM_001375819.1 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_017003527 | chr2:g.25246202C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
XM_005264175.6 | chr2:g.25248174C>A | c.718G>T | p.E240* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|